Literature DB >> 32843407

Premature coronary disease, in-stent restenosis and vascular complications in a young man with Behçet syndrome.

Nathan R Stein1, Satvik Ramakrishna2, Yerem Yeghiazarians2.   

Abstract

A young man with a history of early-onset coronary disease presented with an ST-elevation myocardial infarction at the age of 38. He subsequently had recurrent in-stent restenosis requiring repeating interventions and ultimately bypass surgery. After 4 years, he presents with systemic symptoms, new skin lesions and a femoral artery pseudoaneurysm. He is diagnosed with Behçet syndrome, a rare systemic vasculitis characterised by the triad of oral aphthous ulcers, genital ulcers and ocular involvement. Behçet is not associated with premature coronary disease but can have a variety of cardiac complications. Additionally, pathergy, an exaggerated inflammatory response to local injury, is characteristic. We hypothesise that in retrospect, subclinical inflammation and a vascular pathergy likely predisposed him to his cardiac and vascular complications. Here, we review risk factors and presentation of premature coronary artery disease and review the literature on the cardiovascular complications of Behçet syndrome. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cardiovascular medicine; interventional cardiology; ischaemic heart disease; rheumatology; vasculitis

Mesh:

Year:  2020        PMID: 32843407      PMCID: PMC7449362          DOI: 10.1136/bcr-2020-235039

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

Review 1.  Behçet's disease.

Authors:  T Sakane; M Takeno; N Suzuki; G Inaba
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

2.  Vascular involvement in Behçet's disease: a retrospective analysis of 2319 cases.

Authors:  Rifkiye Sarica-Kucukoglu; Afet Akdag-Kose; Murat KayabalI; Kurtulus Didem Yazganoglu; Rian Disci; Dilek Erzengin; Gulsevim Azizlerli
Journal:  Int J Dermatol       Date:  2006-08       Impact factor: 2.736

3.  Vascular involvement in Behçet's disease.

Authors:  Y Koç; I Güllü; G Akpek; T Akpolat; E Kansu; S Kiraz; F Batman; T Kansu; F Balkanci; S Akkaya
Journal:  J Rheumatol       Date:  1992-03       Impact factor: 4.666

Review 4.  Cardiovascular involvement in Behçet's disease.

Authors:  Yusuf Sezen; Hakan Buyukhatipoglu; Hakan Buyukatipoglu; Zekeriya Kucukdurmaz; Ramazan Geyik
Journal:  Clin Rheumatol       Date:  2009-10-16       Impact factor: 2.980

5.  Acute myocardial infarction in the young--The University of Michigan experience.

Authors:  Michele Doughty; Raj Mehta; David Bruckman; Sugata Das; Dean Karavite; Thomas Tsai; Kim Eagle
Journal:  Am Heart J       Date:  2002-01       Impact factor: 4.749

Review 6.  Subclinical atherosclerosis in Behcet's disease: A systematic review and meta-analysis.

Authors:  Mira Merashli; Irina Chis Ster; Paul Richard Julian Ames
Journal:  Semin Arthritis Rheum       Date:  2015-07-04       Impact factor: 5.532

7.  Atherosclerosis in Behçet's Syndrome.

Authors:  Emire Seyahi; Serdal Ugurlu; Rana Cumali; Huriye Balci; Oktay Ozdemir; Melike Melikoglu; Gulen Hatemi; Izzet Fresko; Vedat Hamuryudan; Sebahattin Yurdakul; Hasan Yazici
Journal:  Semin Arthritis Rheum       Date:  2008-01-25       Impact factor: 5.532

8.  Myocardial infarction in young patients: an analysis by age subsets.

Authors:  B D Hoit; E A Gilpin; H Henning; A A Maisel; H Dittrich; J Carlisle; J Ross
Journal:  Circulation       Date:  1986-10       Impact factor: 29.690

9.  Treatment of venous thrombosis associated with Behcet's disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation.

Authors:  Joong Kyong Ahn; You Sun Lee; Chan Hong Jeon; Eun-Mi Koh; Hoon-Suk Cha
Journal:  Clin Rheumatol       Date:  2007-07-17       Impact factor: 2.980

Review 10.  Major arterial involvement and review of Behcet's disease.

Authors:  Ufuk Alpagut; Murat Ugurlucan; Enver Dayioglu
Journal:  Ann Vasc Surg       Date:  2007-03       Impact factor: 1.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.